How much is Enliven Therapeutics worth in 2026?

Enliven Therapeutics has a current valuation of N/A based on their PIPE round and secondary market data.

How much funding has Enliven Therapeutics raised?

Enliven Therapeutics has raised N/A in total funding across 1 funding rounds.

Enliven Therapeutics

Drug Discovery

Enliven Therapeutics valuation and funding history | Last updated: February 23, 2023 | 1 funding rounds

Current Valuation

N/A

As of February 23, 2023

Total Funding Raised

N/A

Across 1 round

Last Round

PIPE

$165.0M

Last Funding

Feb 2023

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
February 23, 2023	PIPE	$165.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Enliven Therapeutics is currently valued at N/A as of February 23, 2023.

Track Enliven Therapeutics Valuation Updates

Get notified when Enliven Therapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for Enliven Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Enliven Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Enliven Therapeutics Worth in 2026?

Enliven Therapeutics is a leading private company in the Drug Discovery sector. Track Enliven Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Enliven Therapeutics Valuation is Determined

Private company valuations like Enliven Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.